Perioperative assessment of platelet function in patients under antiplatelet therapy

References

• Jennings LK. Role of platelets in atherothrombosis. Am. J. Cardiol.103(3 Suppl.), 4A–10A (2009).
   PubMed Web of Science ®Google Scholar
• King SB 3rd, Smith SC Jr, Hirshfeld JW Jr et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J. Am. Coll. Cardiol.51(2), 172–209 (2008).
   PubMed Web of Science ®Google Scholar
• Reaume KT, Regal RE, Dorsch MP. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Ann. Pharmacother.42(4), 550–557 (2008).
   Google Scholar
• Fitzgerald DJ, Maree A. Aspirin and clopidogrel resistance. Hematology Am. Soc. Hematol. Educ. Program114–120 (2007).
   Google Scholar
• Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy. Am. J. Cardiol.103(3 Suppl.), 27A–34A (2009).
   PubMed Web of Science ®Google Scholar
• Kasotakis G, Pipinos II, Lynch TG. Current evidence and clinical implications of aspirin resistance. J. Vasc. Surg.50(6), 1500–1510 (2009).
   PubMed Web of Science ®Google Scholar
• Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am. J. Cardiol.104(2), 227–233 (2009).
   PubMed Web of Science ®Google Scholar
• Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb. Haemost.89(5), 783–787 (2003).
   PubMed Web of Science ®Google Scholar
• Berger JS. Platelet-directed therapies and coronary artery bypass grafting. Am. J. Cardiol.104(5 Suppl.), 44C–48C (2009).
   Google Scholar
• Rao SV. Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapies. Am. J. Cardiol.104(5 Suppl.), 60C–63C (2009).
   Google Scholar
• Sun JC, Whitlock R, Cheng J et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur. Heart J.29(8), 1057–1071 (2008).
   PubMed Web of Science ®Google Scholar
• Fox KA, Mehta SR, Peters R et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation110(10), 1202–1208 (2004).
   PubMed Web of Science ®Google Scholar
• Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation116(7), e148–e304 (2007).
   PubMed Web of Science ®Google Scholar
• Duke WW. The relation of blood platelets to hemorrhagic disease. By W.W. Duke. JAMA250(9), 1201–1209 (1983).
   PubMed Web of Science ®Google Scholar
• Mielke CH. Measurement of the bleeding time. Thromb. Haemost.52(2), 210–211 (1984).
   PubMed Web of Science ®Google Scholar
• Jennings I, Woods TA, Kitchen S, Walker ID. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J. Clin. Pathol.61(8), 950–954 (2008).
   PubMed Web of Science ®Google Scholar
• Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin. Thromb. Hemost.16(1), 1–20 (1990).
   PubMed Web of Science ®Google Scholar
• Quiroga T, Goycoolea M, Munoz B et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J. Thromb. Haemost.2(6), 892–898 (2004).
   PubMed Web of Science ®Google Scholar
• Peterson P, Hayes TE, Arkin CF et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists’ and American Society of Clinical Pathologists’ position article. Arch. Surg.133(2), 134–139 (1998).
   PubMedGoogle Scholar
• Paivaniemi OE, Maasilta PK, Vainikka TL, Alho HS, Karhunen PJ, Salminen US. Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis. Mediators Inflamm.510254 (2009).
   Google Scholar
• Nicholson NS, Panzer-Knodle SG, Haas NF et al. Assessment of platelet function assays. Am. Heart J.135(5 Pt 2 Suppl.), S170–S178 (1998).
   Google Scholar
• Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature194, 927–929 (1962).
   PubMed Web of Science ®Google Scholar
• O’Brien J R. Platelet aggregation: part I. Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J. Clin. Pathol.15(5), 446–452 (1962).
   PubMed Web of Science ®Google Scholar
• Breddin HK. Can platelet aggregometry be standardized?. Platelets16(3–4), 151–158 (2005).
   PubMed Web of Science ®Google Scholar
• Blais N, Pharand C, Lordkipanidze M, Sia YK, Merhi Y, Diodati JG. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb. Haemost.102(2), 404–411 (2009).
   PubMed Web of Science ®Google Scholar
• Pedersen SB, Grove EL, Nielsen HL, Mortensen J, Kristensen SD, Hvas AM. Evaluation of aspirin response by multiplate whole blood aggregometry and light transmission aggregometry. Platelets20(6), 415–420 (2009).
   PubMed Web of Science ®Google Scholar
• Bouman H, Parlak E, van Werkum J et al. Which platelet function test is suitable to monitor clopidogrel responsiveness?. A pharmacokinetic analysis on the active metabolite of clopidogrel. J. Thromb. Haemost.8(3), 482–488 (2009).
   Google Scholar
• Solinas E, Gobbi G, Dangas G et al. Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes. J. Thromb. Thrombolysis27(1), 36–43 (2009).
   Google Scholar
• McGlasson DL, Fritsma GA. Whole blood platelet aggregometry and platelet function testing. Semin. Thromb. Hemost.35(2), 168–180 (2009).
   PubMed Web of Science ®Google Scholar
• Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J. Lab. Clin. Med.138(3), 152–163 (2001).
   PubMed Web of Science ®Google Scholar
• Harrison P. In vitro measurement of high-shear platelet adhesion and aggregation by the PFA-100. Methods Mol. Biol.272, 215–223 (2004).
   PubMedGoogle Scholar
• Favaloro EJ. Clinical utility of the PFA-100. Semin. Thromb. Hemost.34(8), 709–733 (2008).
   PubMed Web of Science ®Google Scholar
• Lippi G, Franchini M, Brocco G, Manzato F. Influence of the ABO blood type on the platelet function analyzer PFA-100. Thromb. Haemost.85(2), 369–370 (2001).
   PubMed Web of Science ®Google Scholar
• Davies JA, Collins PW, Hathaway LS, Bowen DJ. C1584: effect on von Willebrand factor proteolysis and von Willebrand factor antigen levels. Acta Haematol.121(2–3), 98–101 (2009).
   Google Scholar
• Jilma B, Fuchs I. Detecting aspirin resistance with the platelet function analyzer (PFA-100). Am. J. Cardiol.88(11), 1348–1349 (2001).
   PubMedGoogle Scholar
• McGlasson DL, Fritsma GA. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul. Fibrinolysis19(2), 120–123 (2008).
   PubMed Web of Science ®Google Scholar
• Curvers J, Dielis AW, Heeremans J, van Wersch JW. Platelet function in whole-blood donors is impaired: the effects of painkillers. Transfusion47(1), 67–73 (2007).
   Google Scholar
• Linnemann B, Schwonberg J, Rechner AR, Mani H, Lindhoff-Last E. Assessment of clopidogrel non-response by the PFA-100(R) system using the new test cartridge INNOVANCE(R) PFA P2Y. Ann. Hematol.89(6), 597–605 (2010).
   PubMed Web of Science ®Google Scholar
• Aalto-Setala K, Karhunen PJ, Mikkelsson J, Niemela K. The effect of glycoprotein IIIa PIA 1/A2 polymorphism on the PFA-100 response to GP IIb IIa receptor inhibitors-the importance of anticoagulants used. J. Thromb. Thrombolysis20(1), 57–63 (2005).
   PubMed Web of Science ®Google Scholar
• Koscielny J, von Tempelhoff GF, Ziemer S et al. A practical concept for preoperative management of patients with impaired primary hemostasis. Clin. Appl. Thromb. Hemost.10(2), 155–166 (2004).
   PubMed Web of Science ®Google Scholar
• Savion N, Varon D. Impact – the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response. Pathophysiol. Haemost. Thromb.35(1–2), 83–88 (2006).
   PubMedGoogle Scholar
• Varon D, Lashevski I, Brenner B et al. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am. Heart J.135(5 Pt 2 Suppl.), S187–S193 (1998).
   PubMed Web of Science ®Google Scholar
• Shenkman B, Matetzky S, Fefer P et al. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Thromb. Res.122(3), 336–345 (2008).
   PubMedGoogle Scholar
• Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol. Haemost. Thromb.35(1–2), 67–82 (2006).
   PubMed Web of Science ®Google Scholar
• Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood70(1), 307–315 (1987).
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Krueger LA, Frelinger AL 3rd, Furman MI. Evaluation of platelet function by flow cytometry. Methods21(3), 259–270 (2000).
   PubMed Web of Science ®Google Scholar
• Fox SC, May JA, Shah A, Neubert U, Heptinstall S. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets20(4), 250–259 (2009).
   PubMed Web of Science ®Google Scholar
• Pearson L, Thom J, Adams M et al. A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int. J. Lab. Hematol.31(4), 430–439 (2009).
   PubMed Web of Science ®Google Scholar
• Ramstrom AS, Fagerberg IH, Lindahl TL. A flow cytometric assay for the study of dense granule storage and release in human platelets. Platelets10(2–3), 153–158 (1999).
   PubMed Web of Science ®Google Scholar
• Ault KA. Flow cytometric measurement of platelet function and reticulated platelets. Ann. NY Acad. Sci.677, 293–308 (1993).
   PubMed Web of Science ®Google Scholar
• Frelinger AL 3rd, Furman MI, Linden MD et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation113(25), 2888–2896 (2006).
   PubMed Web of Science ®Google Scholar
• Alstrom U, Granath F, Oldgren J, Stahle E, Tyden H, Siegbahn A. Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. Thromb. Res.124(5), 572–577 (2009).
   PubMedGoogle Scholar
• von Beckerath N, Sibbing D, Jawansky S et al. Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet vasodilator-stimulated phosphoprotein flow cytometry. Blood Coagul. Fibrinolysis21(1), 46-52 (2009).
   Google Scholar
• van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM. The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence. Platelets19(7), 479–488 (2008).
   PubMed Web of Science ®Google Scholar
• Smith JW, Steinhubl SR, Lincoff AM et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation99(5), 620–625 (1999).
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B, Poelz W, Haltmayer M. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease. Clin. Appl. Thromb. Hemost.15(6), 652–659 (2009).
   PubMed Web of Science ®Google Scholar
• Paniccia R, Antonucci E, Maggini N et al. Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy. Am. J. Clin. Pathol.131(6), 834–842 (2009).
   PubMed Web of Science ®Google Scholar
• Velik-Salchner C, Maier S, Innerhofer P et al. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Anesth. Analg.107(6), 1798–1806 (2008).
   PubMed Web of Science ®Google Scholar
• Michelson AD, Frelinger AL 3rd, Furman MI. Current options in platelet function testing. Am. J. Cardiol.98(10A), 4N–10N (2006).
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Kleibeuker M, Postma S et al. A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int. J. Cardiol.140(1), 123–126 (2008).
   PubMed Web of Science ®Google Scholar
• Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analg.106(5), 1366–1375 (2008).
   PubMed Web of Science ®Google Scholar
• Flisberg P, Rundgren M, Engstrom M. The effects of platelet transfusions evaluated using rotational thromboelastometry. Anesth. Analg.108(5), 1430–1432 (2009).
   Google Scholar
• Ganter MT, Schmuck S, Hamiel CR et al. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy. J. Cardiothorac. Vasc. Anesth.22(5), 675–680 (2008).
   PubMed Web of Science ®Google Scholar
• Lang T, Johanning K, Metzler H et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth. Analg.108(3), 751–758 (2009).
   PubMed Web of Science ®Google Scholar
• Collyer TC, Gray DJ, Sandhu R, Berridge J, Lyons G. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping. Br. J. Anaesth.102(4), 492–498 (2009).
   PubMed Web of Science ®Google Scholar
• Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J. Lab. Clin. Med.143(5), 301–309 (2004).
   PubMed Web of Science ®Google Scholar
• Tucci MA, Ganter MT, Hamiel CR, Klaghofer R, Zollinger A, Hofer CK. Platelet function monitoring with the Sonoclot analyzer after in vitro tirofiban and heparin administration. J. Thorac. Cardiovasc. Surg.131(6), 1314–1322 (2006).
   Google Scholar